Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CM.8.1.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XSNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XSNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XSNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.4.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.4.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.4.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.29NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.29NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.38NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.38NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.38NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.2.40NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.2.40NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.40NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.160.25NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.160.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.25NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.74NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.74NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.74NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.6.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.6.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.6.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.238NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.238NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.238NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.68NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.68NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.68NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.7.26NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.7.26NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.7.26NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BR.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BR.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BR.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.1.25NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used